New patent for Nevakar drug EPHEDRINE SULFATE

   December 29, 2020    Comments Off on New patent for Nevakar drug EPHEDRINE SULFATE    Posted in: Patent Added

Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Akorn, Amneal, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Nevakar, and Sandoz Inc and, and is included…

The post New patent for Nevakar drug EPHEDRINE SULFATE appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog